Dimensional Fund Advisors LP Sells 9,585 Shares of HCA Healthcare, Inc. $HCA

Key Points

Error: One or more errors occurred.

Dimensional Fund Advisors LP trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 485,292 shares of the company's stock after selling 9,585 shares during the period. Dimensional Fund Advisors LP owned about 0.20% of HCA Healthcare worth $167,675,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently made changes to their positions in HCA. Cheviot Value Management LLC bought a new position in shares of HCA Healthcare in the first quarter valued at $26,000. Atwood & Palmer Inc. bought a new position in shares of HCA Healthcare in the first quarter valued at $28,000. Bartlett & CO. Wealth Management LLC raised its holdings in shares of HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after purchasing an additional 80 shares during the last quarter. ORG Partners LLC raised its holdings in shares of HCA Healthcare by 344.0% in the first quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after purchasing an additional 86 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. raised its holdings in shares of HCA Healthcare by 75.8% in the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after purchasing an additional 50 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

HCA Healthcare stock traded up $0.61 during mid-day trading on Friday, hitting $404.87. 1,081,188 shares of the company traded hands, compared to its average volume of 1,431,386. The stock has a fifty day moving average price of $373.91 and a 200-day moving average price of $354.02. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The stock has a market cap of $94.74 billion, a price-to-earnings ratio of 17.02, a price-to-earnings-growth ratio of 1.27 and a beta of 1.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period in the prior year, the business posted $5.50 EPS. The firm's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is currently 12.11%.

Analysts Set New Price Targets

Several brokerages have recently commented on HCA. Robert W. Baird increased their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a "neutral" rating in a report on Thursday, August 14th. Morgan Stanley lowered their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a report on Monday, July 28th. Barclays decreased their price objective on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a report on Monday, July 28th. Truist Financial lifted their target price on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. Finally, JPMorgan Chase & Co. lifted their target price on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $398.58.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.